Dr. Reddy's Laboratories
RDY
#1699
Rank
A$17.86 B
Marketcap
A$21.36
Share price
0.35%
Change (1 day)
-4.18%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Net assets

Net assets on the balance sheet as of September 2025 : A$6.13 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has A$6.13 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dr. Reddy's Laboratories - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-03-31$A$6.32 B22.69%
2024-03-31$A$5.15 B22.7%
2023-03-31$A$4.19 B25.31%
2022-03-31$A$3.35 B7.62%
2021-03-31$A$3.11 B-7.15%
2020-03-31$A$3.35 B18.12%
2019-03-31$A$2.83 B12.27%
2018-03-31$A$2.52 B1.08%
2017-03-31$A$2.50 B-0.97%
2016-03-31$A$2.52 B7.65%
2015-03-31$A$2.34 B43.67%
2014-03-31$A$1.63 B26.77%
2013-03-31$A$1.28 B18.36%
2012-03-31$A$1.08 B8.7%
2011-03-31$A$1.00 B-4.21%
2010-03-31$A$1.04 B-12.18%
2009-03-31$A$1.19 B-7.23%
2008-03-31$A$1.28 B7.34%
2007-03-31$A$1.19 B69.36%
2006-03-31$A$0.70 B13.18%
2005-03-31$A$0.62 B-3.37%
2004-03-31$A$0.64 B-1.42%
2003-03-31$A$0.65 B10.4%
2002-03-31$A$0.59 B155.16%
2001-03-31$A$0.23 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$140.15 B 2,184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$10.92 B 77.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$31.88 B 419.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$67.37 B 998.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$129.92 B 2,017.40%๐Ÿ‡ซ๐Ÿ‡ท France